about
High-resolution analysis of aberrant regions in autosomal chromosomes in human leukemia THP-1 cell line.Targeting signal transduction pathways to eliminate chemotherapeutic drug resistance and cancer stem cells.Loss of p73 promotes dissemination of Myc-induced B cell lymphomas in miceA phase I study of immune gene therapy for patients with CLL using a membrane-stable, humanized CD154Induction of TAp73 by platinum-based compounds to overcome drug resistance in p53 dysfunctional chronic lymphocytic leukemiaMdm2 overexpression and p73 loss exacerbate genomic instability and dampen apoptosis, resulting in B-cell lymphoma.CDKN2B, SLC19A3 and DLEC1 promoter methylation alterations in the bone marrow of patients with acute myeloid leukemia during chemotherapySpecific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation.DNA methylation and leukemia susceptibility in China: Evidence from an updated meta-analysis.Gene expression of WWOX, FHIT and p73 in acute lymphoblastic leukemiaTargeting the leukemic stem cell: the Holy Grail of leukemia therapyImpact of aberrant DNA methylation patterns including CYP1B1 methylation in adolescents and young adults with acute lymphocytic leukemia.Tumor suppressor gene methylation on the short arm of chromosome 1 in chronic myelogenous leukemia.Regulation of p38, PKC/Foxo3a/p73 signaling network by GTP during erythroid differentiation in chronic myelogenous leukemia.PU.1 binding to the p53 family of tumor suppressors impairs their transcriptional activity.Kinase activity profiling reveals active signal transduction pathways in pediatric acute lymphoblastic leukemia: a new approach for target discovery.
P2860
Q33487434-715B3970-F6C1-4D1C-B3BF-6F979ECEE293Q33823577-F0E00425-6F31-45BC-B0ED-D0C664060732Q33882866-E5EE8B62-8091-48B9-86B1-79F5187CB796Q36016148-8B7DBF9F-DCF2-4E5E-9207-F16C38CCDB0CQ36118111-A4580914-C4D4-43F9-A4BF-AC61AC73B5C0Q36218273-E881FC93-6B12-4707-A1B1-E2884B4329F1Q36824910-75B6F195-D79A-41A6-9A95-76C9DFED5DFCQ37162851-FAA0A6FB-39E4-4414-BED1-9978267506F9Q37204096-82C36C7D-A6DE-4F35-9B1C-A6A8681A21B5Q37229433-3CFF6BF0-2B75-4760-BA45-83383A7A80FBQ37272565-DD037F85-65ED-4FB2-ACCE-6C3FC113AFA8Q37627410-AED303B8-9467-4348-B1A5-AEB736ACB788Q48303173-9EB7E719-CB31-41ED-BECA-EE33235AA39FQ51825137-E982D0CD-AA41-4301-8FD6-703F412E2B3AQ52584538-09E46987-0720-49D2-9DE9-88E2D0FAAE3BQ54308039-22B0C0F6-A8ED-44F1-9E81-2990121C7396
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
The role of p73 in hematological malignancies.
@ast
The role of p73 in hematological malignancies.
@en
type
label
The role of p73 in hematological malignancies.
@ast
The role of p73 in hematological malignancies.
@en
prefLabel
The role of p73 in hematological malignancies.
@ast
The role of p73 in hematological malignancies.
@en
P2093
P2860
P356
P1433
P1476
The role of p73 in hematological malignancies.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.LEU.2404166
P577
2006-05-01T00:00:00Z